Scientists at the Terasaki Institute for Biomedical Innovation (TIBI), led by Dr. Vadim Jucaud (Assistant Professor), have ...

Amidst the continued struggle to treat non-small-cell lung cancer, a new study led by Stanford University scientists suggests that a patient's response to immunotherapy may hinge on how immune cells ...

Prostate cancer (PCa) remains a leading cause of cancer-related mortality globally, with late-stage diagnoses contributing to ...

The funds will support multiple new and ongoing clinical trials of Tilt's oncolytic adenoviral therapy TILT-123.

Notch signaling and epithelial-to-mesenchymal transition (EMT). Transformed, recruited and differentially activated cells surrounding the tumor form the tumor microenvironment. These cells inhibit ...

CAF: cancer‐associated fibroblasts; EMT: epithelial‐to‐mesenchymal transition ... should be developed to assess the fate of these tumor states within their native microenvironment. With these new ...

CytomX Therapeutics, Inc. (Nasdaq: CTMX), a leader in the field of masked, conditionally activated biologics, today announced new preclinical data in collaboration with Moderna on an mRNA encoded ...

The tumor microenvironment (TME ... in TAFs has been linked to enhanced migration and invasiveness of ovarian epithelial carcinoma cells. TAFs are also involved in the development of therapy ...

According to a new report, the global Tumor Microenvironment Market will grow from US$ 1.47 Billion in 2023 to US$ 3.43 billion by 2030 at a compounded annual growth rate (CAGR) of 12.9% during the ...

Through a comprehensive study of fibroblasts in the tumor environment, including their interaction with other cells such as epithelial ... roles in the tumor microenvironment Two of these subtypes ...

"When we think about solid tumors, they are primarily in epithelial locations ... immunosuppressive microenvironment that "can shut down any kind of anti-tumor response in the brain." ...